PRPO UP Thur 43%, Up Fri 11%, Up Both Days AH's and PM hours. Next week should be very strong imo
VA orders and announces approval of Cancer Biopsy Test is BIG NEWS
" Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), today announced that it has been approved by the United States Department of Defense (DoD) as a domestic vendor "
and " Precipio Announces First US Government Customer for ICE COLD-PCR™ Mutation Enrichment Technology"
and
" Department of Defense Approves Precipio as a Vendor for its Liquid Biopsy Testing "
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.